Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Patient Insights into the Design of Technology to Support a Strengths-Based Approach to Health Care.

Greater intake of dietary omega-3 fatty acids associated with lower risk of diabetic retinopathy

SURVEY: Weight Management & Chronic Illness

Japanese green tea consumers have reduced risk of dementia

Researchers find herpes strain in the nervous system

Do Nothing, Accomplish Everything! The Connection Between Breathing and Healing

Nature Heals

Best Herbs to Help With Insomnia

Meet the ProHealth Editors

Choline: Why You Should Eat Your Egg Yolks and Take Krill

 
Print Page
Email Article

FDA Backs New Alzheimer’s Drug: Memantine

  [ 224 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 25, 2003


WASHINGTON, Sept. 25 — A drug long used in Germany to ease the ravages of Alzheimer’s disease took a step toward the U.S. market on Wednesday when government scientists backed memantine as the first treatment specifically for late stages of the mind-stealing disease.

BUT THE Food and Drug Administration’s advisers struggled with how much benefit memantine actually offers, and if it could give false hope to families of the most severely ill patients.

“I believe this to be a very small effect size,” cautioned the panel’s chairwoman, Dr. Claudia Kawas of the University of California, Irvine. “The entire committee has certain concerns.”

When it comes to benefit for the most severe Alzheimer’s patients, “I’m very unimpressed,” added Dr. Roger Packer, a neuroscientists in Washington.

Still, the FDA panel voted unanimously that memantine does offer some benefit to people with moderate to severe Alzheimer’s symptoms, and is safe enough to try.

If the FDA ultimately agrees, memantine would mark an important step in Alzheimer’s therapy. The nation’s four other Alzheimer’s medications are designated for early stages of the disease, and they work on a different brain chemical than memantine. The new drug could let doctors, for the first time, prescribe drug combinations in hopes of better results.

The FDA is not bound by its advisers’ recommendations but typically follows them. A decision could come as early as this fall.

Families out of options are anxiously awaiting memantine; many now try to buy supplies overseas via the Internet. The drug’s U.S. marketer, Forest Laboratories, says it receives over 1,000 calls a month from families desperate to buy it in this country.

“These are priceless moments regained,” said Barry Cooper of Arlington, Va., who told the FDA panel that his wife, Linda, talks more and regained some small skills since starting memantine bought abroad.

“Every month can count,” he added, urging that FDA act quickly.

Memantine is not miraculous, even company-affiliated researchers acknowledged. But it can help stabilize patients so that they maintain certain functions for a few months longer, said Dr. Pierre Tariot of the University of Rochester, who led one of the critical studies.

He said studies suggest memantine gives some patients the ability go to the toilet independently for six more months, “and that’s very important.”

It is not known if memantine might help in earlier stages of Alzheimer’s. Studies of that question are in progress.

Forest has not announced a projected U.S. price. One Internet site advertises the drug for about $146 for a month’s supply.

About 4 million Americans have Alzheimer’s, and a million of them are believed to suffer severe symptoms. There is no known cure or prevention.

A six-month study of patients with moderate to severe Alzheimer’s symptoms found those given memantine worsened significantly slower — by one measure, at half the pace, according to researchers. In a second study, patients taking the older Alzheimer’s drug Aricept found added benefit when they took memantine, too.

Some patients reported actual improvements in memory and thinking skills. For the majority, however, the drug simply slowed the pace of deterioration.

FDA panelists could not say how much benefit patients got. More confusing, when FDA’s scientists looked at just the most severely ill patients, in one study memantine seemed to have no effect and only moderately ill patients were helped.

FDA’s advisers could not say how the average doctor would know who should get the pill and when the medication would be a waste of time.

Today’s Alzheimer’s drugs — Aricept, Exelon, Reminyl and Cognex — delay the breakdown of a brain chemical called acetylcholine that is vital for nerve cells to communicate. Memantine blocks excess amounts of another brain chemical, called glutamate, that can damage or kill nerve cells.

Memantine has been sold in Germany for two decades to treat various brain diseases, with few, mild side effects reported to date. In 1999, the first large studies suggesting memantine helped advanced Alzheimer’s were published, prompting U.S. research.

German drug-maker Merz Pharmaceuticals last year won Europe-wide approval of memantine for advanced Alzheimer’s, and Forest Laboratories filed for FDA approval in late December.

© 2003 Associated Press. All rights reserved.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Energy NADH™ 12.5mg Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Undenatured Type II Collagen - Chicken Soup for Your Joints Undenatured Type II Collagen - Chicken Soup for Your Joints
Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol
Restore Youthful Cognition and Well-Being Restore Youthful Cognition and Well-Being
Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map